Search / 639 results found

from
to
  • Updated

STRASBOURG, France and PHILADELPHIA, Feb. 26, 2021 /PRNewswire/ -- Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options, today announced its recognition of Rare Disease Day 2021. Dynacure is helping to raise awareness of myotubular and centronuclear myopathies, or CNM, by publishing a series of stories from patients and families who have been affected by this group of rare and life-threatening disorders.

  • Updated

MONROEVILLE, Pa., Feb. 25, 2021 /PRNewswire/ -- Following what is expected to be the deadliest overdose year in recorded history, Recovery Centers of America (RCA), one of the nation's top addiction treatment providers focused on comprehensive evidence-based care, announced today that it has opened their first western Pennsylvania location. The 78,000 square foot,138-bed treatment center located at 2380 McGinley Road in Monroeville, Pennsylvania, which recently underwent multi-million-dollar renovations, will provide world-class, affordable, in-network treatment for patients and their families. RCA at Monroeville represents the organization's 10th inpatient facility spanning a half-dozen states, providing patients access to life-changing treatment developed by noted national experts on substance use disorder treatment ("SUD"). RCA at Monroeville will also bring nearly 150  jobs to the community.

  • Updated

PHILADELPHIA, Feb. 24, 2021 /PRNewswire/ -- Today Independence Blue Cross (Independence) and Quartet Health (Quartet) announced they will work together to launch a whole person health initiative in Southeastern Pennsylvania to address behavioral health needs by helping people easily access the most appropriate care for them.

  • Updated

RADNOR, Pa., Feb. 23, 2021 /PRNewswire/ -- NeuroRx, Inc. announced today that the Phase 2b/3 trial* of ZYESAMI™ (aviptadil, previously RLF-100™) for the treatment of Respiratory Failure in critically ill patients with Covid-19 has demonstrated multidimensional benefit around its prespecified primary endpoint of Recovery from Respiratory Failure with discharge from hospital and ICU (without relapse) by day 28 in patients with critical Covid-19 who were treated with High Flow Nasal Oxygen. Although not envisioned at the start of the clinical trial, High Flow Nasal Oxygen has become the predominant form of treatment in Covid-19 respiratory failure, with mechanical ventilation reserved for those whose blood oxygen levels cannot be maintained on this less invasive modality. The trial was conducted at 10 U.S. hospitals under the direction of NeuroRx in collaboration with RELIEF THERAPEUTICS Holding AG (SIX: RLF; OTCQB: RLFTF). NeuroRx has signed an agreement to complete a business combination with Big Rock Partners Acquisition Corporation (NASDAQ:BRPA).

  • Updated

PHILADELPHIA, Feb. 23, 2021 /PRNewswire/ -- ERT, the global leader in clinical endpoint data collection, today announced a powerful new solution for enabling the collection, processing and analysis of photos and audio as part of clinical trial eCOA assessments. This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality and data security.

  • Updated

PHILADELPHIA, Feb. 23, 2021 /PRNewswire/ -- Blackfynn, a company using a systematic approach that combines data, technology and disease-specific clinical expertise to develop a growing pipeline of targeted, clinical-stage therapeutics for Parkinson's and neurodegeneration, today announced that Stephen Hahn, M.D. will join its Board of Directors.

BIG RUN — One person died in a three-vehicle crash Monday morning in Big Run, according to authorities.

  • Updated

WASHINGTON and PLYMOUTH MEETING, Pa., Feb. 22, 2021 /PRNewswire/ -- Today, the National Comprehensive Cancer Network® (NCCN®), American Cancer Society Cancer Action Network (ACS CAN) and the National Minority Quality Forum (NMQF) presented new ideas for overcoming inequality in oncology. The recommendations—developed by a group of 17 national experts, representing patients and advocates, caregivers, healthcare providers, researchers, and industry—directly address how medical systems in the United States often disproportionately fail minority patients, particularly those who are Black and/or Indigenous, and draws on extensive polling data from a recent poll fielded by Public Opinion Strategies on behalf of the organizations to make clear the case for urgent action.